Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507
Article
CAS
PubMed
Google Scholar
Reardon DA, Rich JN, Friedman HS, Bigner DD (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24(8):1253–1265
Article
CAS
PubMed
Google Scholar
Mrugala MM (2013) Advances and challenges in the treatment of glioblastoma: a clinician’s perspective. Discov Med 15(83):221–230
PubMed
Google Scholar
Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M et al (2010) Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 16(8):2443–2449
Article
PubMed Central
CAS
PubMed
Google Scholar
Li GH, Wei H, Lv SQ, Ji H, Wang DL (2010) Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells. Int J Oncol 37(1):103–110
Article
PubMed
Google Scholar
Villalva C, Martin-Lanneree S, Cortes U, Dkhissi F, Wager M, Le Corf A et al (2011) STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy? Int J Cancer 128(4):826–838
Article
CAS
PubMed
Google Scholar
Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP et al (2014) Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta 1845(2):136–154
CAS
PubMed
Google Scholar
Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I et al (2007) A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 26(17):2435–2444
Article
CAS
PubMed
Google Scholar
Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ (2002) Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21(55):8404–8413
Article
CAS
PubMed
Google Scholar
He K, Qi Q, Chan CB, Xiao G, Liu X, Tucker-Burden C et al (2013) Blockade of glioma proliferation through allosteric inhibition of JAK2. Sci Signal 6(283):ra55
Atkinson GP, Nozell SE, Benveniste ET (2010) NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 10(4):575–586
Article
CAS
PubMed
Google Scholar
Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J et al (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21(13):2000–2008
Article
CAS
PubMed
Google Scholar
Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264(5164):1415–1421
Article
CAS
PubMed
Google Scholar
Lichtor T, Libermann TA (1994) Coexpression of interleukin-1 beta and interleukin-6 in human brain tumors. Neurosurgery 34(4):669–672 (discussion 672–663)
Article
CAS
PubMed
Google Scholar
Jing N, Tweardy DJ (2005) Targeting Stat3 in cancer therapy. Anticancer Drugs 16(6):601–607
Article
CAS
PubMed
Google Scholar
Senft C, Priester M, Polacin M, Schroder K, Seifert V, Kogel D et al (2011) Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101(3):393–403
Article
CAS
PubMed
Google Scholar
Kim JE, Patel M, Ruzevick J, Jackson CM, Lim M (2014) STAT3 activation in glioblastoma: biochemical and therapeutic implications. Cancers (Basel) 6(1):376–395
Article
CAS
Google Scholar
Stechishin OD, Luchman HA, Ruan Y, Blough MD, Nguyen SA, Kelly JJ et al (2013) On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells. Neuro Oncol 15(2):198–207
Article
PubMed Central
CAS
PubMed
Google Scholar
See AP, Han JE, Phallen J, Binder Z, Gallia G, Pan F et al (2012) The role of STAT3 activation in modulating the immune microenvironment of GBM. J Neurooncol 110(3):359–368
Article
PubMed Central
CAS
PubMed
Google Scholar
Pardanani A, Hood J, Lasho T, Levine RL, Martin MB, Noronha G et al (2007) TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations. Leukemia 21(8):1658–1668
Article
CAS
PubMed
Google Scholar
Pardanani A, Gotlib JR, Jamieson C, Cortes JE, Talpaz M, Stone RM et al (2011) Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis. J Clin Oncol 29(7):789–796
Article
CAS
PubMed
Google Scholar
Ramakrishnan V, Kimlinger T, Haug J, Timm M, Wellik L, Halling T et al (2010) TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45 + myeloma cells. Am J Hematol 85(9):675–686
Article
PubMed Central
CAS
PubMed
Google Scholar
Sun Y, Moretti L, Giacalone NJ, Schleicher S, Speirs CK, Carbone DP et al (2011) Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models. J Thorac Oncol 6(4):699–706
Article
PubMed Central
PubMed
Google Scholar
Ferrajoli A, Faderl S, Van Q, Koch P, Harris D, Liu Z et al (2007) WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res 67(23):11291–11299
Article
CAS
PubMed
Google Scholar
Aguirre-Gamboa R, Gomez-Rueda H, Martinez-Ledesma E, Martinez-Torteya A, Chacolla-Huaringa R, Rodriguez-Barrientos A et al (2013) SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS ONE 8(9):e74250
Article
PubMed Central
CAS
PubMed
Google Scholar
Wong K, Young GS, Makale M, Hu X, Yildirim N, Cui K et al (2011) Characterization of a human tumorsphere glioma orthotopic model using magnetic resonance imaging. J Neurooncol 104(2):473–481
Article
PubMed Central
PubMed
Google Scholar
Mukthavaram R, Jiang P, Saklecha R, Simberg D, Bharati IS, Nomura N et al (2013) High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile. Int J Nanomedicine 8:3991–4006
PubMed Central
PubMed
Google Scholar
de la Iglesia N, Konopka G, Lim KL, Nutt CL, Bromberg JF, Frank DA et al (2008) Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 28(23):5870–5878
Article
PubMed Central
PubMed
Google Scholar
Inda MM, Bonavia R, Seoane J (2014) Glioblastoma multiforme: a look inside its heterogeneous nature. Cancers (Basel) 6(1):226–239
Article
Google Scholar
Lin L, Deangelis S, Foust E, Fuchs J, Li C, Li PK et al (2010) A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells. Mol Cancer 9:217
Article
PubMed Central
CAS
PubMed
Google Scholar
Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R et al (2001) Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 107(3):351–362
Article
PubMed Central
CAS
PubMed
Google Scholar
Hussain SF, Kong LY, Jordan J, Conrad C, Madden T, Fokt I et al (2007) A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res 67(20):9630–9636
Article
CAS
PubMed
Google Scholar
Nakada M, Kita D, Watanabe T, Hayashi Y, Teng L, Pyko IV et al (2011) Aberrant signaling pathways in glioma. Cancers (Basel) 3(3):3242–3278
Article
CAS
Google Scholar
Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN et al (2011) Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun 406(4):643–648
Article
PubMed Central
CAS
PubMed
Google Scholar
Hong S, Song MR (2014) STAT3 but not STAT1 is required for astrocyte differentiation. PLoS ONE 9(1):e86851
Article
PubMed Central
PubMed
Google Scholar
Minogue AM, Barrett JP, Lynch MA (2012) LPS-induced release of IL-6 from glia modulates production of IL-1beta in a JAK2-dependent manner. J Neuroinflammation 9:126
Article
PubMed Central
CAS
PubMed
Google Scholar